EP3185867
Kristöllunaraðferð á arípíprasól-afleiðum í forðasamsetningum til meðhöndlunar á geðklofa
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.8.2015EP published:
13.1.2021EP application number:
15836431.5
EP translation filed:
23.3.2021Grant published:
15.4.2021EPO information:
European Patent Register
Max expiry date:
23.8.2035Expiry date:
23.8.2026Next due date:
31.8.2026
Title:
CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
Timeline
Today
24.8.2015EP application
13.1.2021EP Publication
23.3.2021Translation submitted
15.4.2021Registration published
23.8.2026Expires
Owner
Name:
Alkermes Pharma Ireland LimitedAddress:
Connaught House 1 Burlington Road, Dublin 4, IE
Inventor
Name:
MORALES, Wilfredo Jr.Address:
Morrow, OH 45152, US
Name:
ZEIDAN, Tarek A.Address:
Lexington, Massachusetts 02420, US
Name:
CHIARELLA, Renato A.Address:
Cambridge, Massachusetts 02139, US
Name:
WRIGHT, Steven G.Address:
Madeira, Ohio 45243, US
Name:
PERRY, Jason M.Address:
Cambridge, Massachusetts 02140, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462041341 PDate:
25.8.2014Country:
US
Classification
Categories:
C07D 401/12, A61K 31/496
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.10.2021
Expires: 23.8.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 2.8.2022
Expires: 23.8.2023
Payer: Patice ehf.
Number: 9
Paid: 3.8.2023
Expires: 23.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.8.2024
Expires: 23.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.8.2025
Expires: 23.8.2026
Payer: Árnason Faktor ehf.